Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Heba W. Alhamdi; Mohammad Y. Alfaifi; Ali A. Shati; Serag Eldin I. Elbehairi; Mohammed Er-rajy; Reda F. M. Elshaarawy; Yasser A. Hassan; Rozan Zakrya

doi:10.1039/D4RA90101K

Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Heba W. Alhamdi,^a Mohammad Y. Alfaifi,^bc Ali A. Shati,^bc Serag Eldin I. Elbehairi,^bcd Mohammed Er-rajy,^e Reda F. M. Elshaarawy,*^f Yasser A. Hassan^gh and Rozan Zakryaⁱ

Author affiliations

* Corresponding authors

^a College of Sciences, Biology Department, King Khalid University, Abha 61413, Saudi Arabia

^b King Khalid University, Faculty of Science, Biology Department, Abha 9004, Saudi Arabia

^c Tissue Culture and Cancer Biology Research Laboratory, King Khalid University, Abha, Saudi Arabia

^d Cell Culture Lab, Egyptian Organization for Biological Products and Vaccines (VACSERA Holding Company), 51 Wezaret El-Zeraa St., Agouza, Giza, Egypt

^e LIMAS Laboratory, Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, Fez, Morocco

^f Department of Chemistry, Faculty of Science, Suez University, 43533 Suez, Egypt
E-mail: reda.elshaarawy@suezuniv.edu.eg

^g College of Pharmacy, Al-Kitab University, Kirkuk 36015, Iraq

^h Department of Pharmaceutics, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt

ⁱ Chemistry Department, Faculty of Science, Port-Said University, Port-Said, Egypt
E-mail: rzakrya@yahoo.com

Abstract

Correction for ‘New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies’ by Heba W. Alhamdi et al., RSC Adv., 2024, 14, 28555–28568, https://doi.org/10.1039/D4RA04219K.

Associated articles

Article information

DOI: https://doi.org/10.1039/D4RA90101K
Article type: Correction
Submitted: 12 Sep 2024
Accepted: 12 Sep 2024
First published: 19 Sep 2024
This article is Open Access

Download Citation

RSC Adv., 2024,14, 29890-29890

Permissions

Request permissions

Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

H. W. Alhamdi, M. Y. Alfaifi, A. A. Shati, S. E. I. Elbehairi, M. Er-rajy, R. F. M. Elshaarawy, Y. A. Hassan and R. Zakrya, RSC Adv., 2024, 14, 29890 DOI: 10.1039/D4RA90101K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

RSC Advances

Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Social activity

Search articles by author

Spotlight

Advertisements